Amprius Technologies Inc FY2024 Q3 Financial Analysis: Net Loss Decreased 28.1%

Executive Summary

Amprius Technologies, Inc. (AMPX) reported its third quarter of FY2024 with a net loss of $10.85 million, representing a 28.1% improvement compared to a net loss of $15.07 million in the same period last year. Despite ongoing challenges in revenue generation, the company demonstrated significant reductions in net loss and cash burn, indicating progress in operational efficiency and strategic adjustments. The company’s total assets stood at $104.21 million, with a strong cash position of $36.30 million at quarter-end, supporting its liquidity profile amid a competitive and evolving market landscape.

Management Discussion and Analysis

Amprius continues to focus on scaling its innovative battery technology, with revenue increasing from $3.3 million in Q3 FY2021 to $7.86 million in Q3 FY2024, though revenue remains below operational costs. The gross margin remains negative at approximately -65%, reflecting high production costs relative to sales. Operating expenses, including R&D and SG&A, have decreased as a percentage of revenue, but the company still reports substantial net losses. Cash flow from operations remains negative at approximately $9.53 million, primarily due to working capital adjustments and high R&D investments. The company’s liquidity remains robust with over $36 million in cash, and its leverage is manageable with total liabilities of $48.21 million against total assets of $104.21 million.

Income Statement Analysis

Revenue for Q3 FY2024 was $7.86 million, up from $2.80 million in the prior year, a 180% increase YoY, driven by increased sales volume. However, gross profit remains negative at -$5.10 million, with gross margin at -65%, indicating ongoing cost challenges. Operating expenses totaled $6.15 million, including R&D expenses of $1.82 million, leading to an operating loss of $11.25 million. Net income from continuing operations was a loss of $10.85 million, a 28.1% improvement from the previous year’s loss of $8.49 million, reflecting some operational progress but still significant losses. Earnings per share (EPS) stood at -$0.0983, consistent with prior periods, with a weighted average share count of approximately 110.4 million shares.

Balance Sheet Analysis

At the end of Q3 FY2024, Amprius reported total assets of $104.21 million, with cash and cash equivalents of $36.30 million. Current assets totaled $44.94 million, including receivables of $4.59 million and inventory of $2.66 million. Total liabilities were $48.21 million, with current liabilities of $13 million and long-term lease obligations of $35.21 million. Shareholders’ equity was $56 million, with a significant accumulated deficit of approximately $163 million. The company’s net debt position improved to approximately $2.22 million, reflecting a reduction in leverage compared to previous periods, supported by cash reserves and manageable debt levels.

Cash Flow Analysis

Operating cash flow for Q3 FY2024 was negative at approximately $9.53 million, primarily due to net losses and working capital changes. Investing activities involved capital expenditures of about $1.33 million, mainly for property, plant, and equipment. Financing activities resulted in net cash outflows of $540,000, mainly from other financing activities. The company’s free cash flow was negative at approximately $10.86 million, indicating ongoing cash burn but with a notable reduction compared to previous periods, supported by a strong cash position at quarter-end.

Ratios & DuPont Analysis

Key financial ratios include a net margin of -138%, reflecting the company’s ongoing losses relative to revenue. Return on assets (ROA) is approximately -10.4%, and return on equity (ROE) is about -19.4%, indicating significant profitability challenges. Asset turnover is roughly 0.075, and the equity multiplier is approximately 1.86, suggesting moderate leverage. These ratios highlight the company’s early-stage operational profile with substantial room for improvement in profitability and efficiency.

Risk Factors

Amprius faces several risks including technological competition, market adoption rates, regulatory hurdles, and operational scalability. Market volatility and macroeconomic factors could impact funding and customer demand. The company’s high R&D expenses and ongoing losses pose financial sustainability risks, while supply chain disruptions could affect production costs. Strategic execution and market positioning remain critical to mitigate these risks and achieve long-term growth.

Notes & Additional Commentary

The company’s negative gross profit underscores the need for cost reductions and process optimization. The substantial increase in revenue YoY is promising but still insufficient to cover operating costs. The reduction in net loss QoQ indicates progress, yet profitability remains distant. Unusual items include significant stock-based compensation and lease obligations, which impact cash flow and profitability metrics. The company’s focus on scaling production and expanding market share will be vital in the coming quarters.

Investment Implications

While Amprius demonstrates promising revenue growth and a solid cash buffer, its persistent losses and negative margins highlight the need for cautious optimism. Short-term opportunities may include leveraging technological advancements and strategic partnerships to accelerate revenue. Long-term risks involve achieving operational profitability and market acceptance. Investors should monitor cash burn rates, cost management, and market developments to assess the company’s trajectory and potential for sustainable growth.